Jose Medina-Inojosa MD MSc

Assistant Professor of Epidemiology Mayo Clinic College of Medicine Researcher
Mayo Clinic Graduate School of Biomedical Sciences 2014-2016
Doctor of Medicine (M.D.), Medicine 2003-2010
Research
Cardiology
Healthcare
Preventive Medicine
Epidemiology
Pulmonary Disease

Register to MarketScale.com for Jose Medina-Inojosa episodes, events, and more.


Already have an account?

Recent Posts

Image
Healthcare

Revolutionizing Cardiology: Telehealth's Game-Changing Role in Modern Heart Treatment

Jose Medina-Inojosa - January 19, 2024

The integration of digital health into cardiological care is revolutionizing cardiology and transforming patient treatment and management, especially in the wake of the COVID-19 pandemic. Telehealth, a key component of digital health, has emerged as a vital tool for cardiologists, enabling them to overcome traditional barriers to patient access.

Read more
Image
Articles

PTZ Cameras are Revolutionizing Medical Care in Vital and Critical Areas

Jose Medina-Inojosa - January 18, 2024

For a brief health segment, Dr. Jose Medina-Inojosa, Assistant Professor of Epidemiology Mayo Clinic, discussed the transformative impact that PTZ (Pan-Tilt-Zoom) cameras have in healthcare, particularly in intensive care, telestroke units, and remote collaboration in medical settings.

Read more
Image
Healthcare

Revolutionary Advancements in Hypertension Treatment: Zilebesiran Redefines the Landscape

Jose Medina-Inojosa - July 25, 2023

Assistant Professor of Epidemiology for the Mayo Clinic College of Medicine at Mayo Clinic, Jose Medina-Inojosa MD MSc, breaks down the groundbreaking innovation in hypertension treatment with the introduction of Zilebesiran. Published in the prestigious New England Journal of Medicine, this study has ignited excitement in the medical community, offering new hope for the millions affected by hypertension, the notorious "silent killer.

Read more
Image
American Heart Association

Next Steps in Hypertension Management

Jose Medina-Inojosa - November 30, 2022

We tested the hypothesis that BF content measured by air displacement plethysmography (Bod-Pod®) had a stronger association with prevalent hypertension (HTN), diabetes mellitus (DM) and dyslipidemia (DLP) when compared to BMI.

Read more
Image
American Heart Association

Association Between Arrhythmia Burden During Clinical Exercise Testing and All-Cause Mortality

Jose Medina-Inojosa - November 30, 2022

Arrhythmias commonly occur during clinical exercise stress testing (EST), however there are limited data on prognostic significance, particularly differences between individuals with minor versus significant arrhythmia burden. We hypothesized that significant but not minor arrhythmia burden during EST would be predictive of future all-cause mortality.

Read more
Image
Articles

Mayo Clinic Doctor Says Mark Cuban's Cost Plus Drugs is Bringing "Access" to U.S. Healthcare

Jose Medina-Inojosa - November 11, 2022

Mark Cuban's Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of the prescription price that Big Pharma puts on the marketplace.

Read more